154 results

• Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues

  October 28, 2025

  Irvin Jackson

  Plaintiffs and defendants involved in GLP-1 stomach paralysis lawsuits are being given more time to prepare arguments over whether the cases are preempted by federal law and if there is evidence that can prove the drugs cause gastroparesis injuries.

• Ozempic, Wegovy Kidney Side Effects Highlighted in New Study

  October 10, 2025

  Irvin Jackson

  New research reviewing adverse event reports to the FDA links Ozempic and Wegovy to an increased risk of acute kidney injuries.

• Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue

  October 7, 2025

  Irvin Jackson

  Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation.

• Reports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s

  October 3, 2025

  Irvin Jackson

  Reports of “Ozempic teeth” are growing, as dentists warn GLP-1 medications may cause bad breath, dental erosion and other oral health issues.

• Study Raises New Questions Over Ozempic Hair Loss Risks

  September 26, 2025

  Irvin Jackson

  Researchers are calling for doctors to warn patients about potential Ozempic and Mounjaro hair loss risks, which may increase with weight loss.

• Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges

  September 24, 2025

  Irvin Jackson

  A lawsuit over Mounjaro side effects claims the diabetes drug led to a bowel obstruction resulting in permanent injuries.

• Woman Files Trulicity and Ozempic Lawsuit Over Ileus, Intestinal Obstruction

  September 5, 2025

  Irvin Jackson

  A lawsuit against the makers of Ozempic and Trulicity claims the side effects caused a woman's intestines to stop contracting, leading to a dangerous intestinal blockage.

• GLP-1 Side Effects May Increase Kidney Cancer Risks: Study

  September 3, 2025

  Irvin Jackson

  New research suggests GLP-1 drugs may lower the risk of certain cancers, but could also raise the likelihood of developing kidney cancer.

• MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers

  August 29, 2025

  Irvin Jackson

  Eli Lilly seeks to consolidate all GLP-1 vision loss lawsuits into a new MDL, and assign them to the same court where the drugs' gastroparesis injury cases are being held.

• Gastric Emptying Study Will Be Required in Ozempic Gastroparesis Lawsuits: MDL Order

  August 20, 2025

  Irvin Jackson

  All plaintiffs filing Ozempic gastroparesis lawsuits, or gastroparesis claims involving other GLP-1 drugs, must be diagnosed through a number of court-approved gastric emptying studies.